These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30677746)

  • 61. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
    Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
    Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Apolipoprotein E and central nervous system disorders: reviews of clinical findings.
    Takeda M; Martínez R; Kudo T; Tanaka T; Okochi M; Tagami S; Morihara T; Hashimoto R; Cacabelos R
    Psychiatry Clin Neurosci; 2010 Dec; 64(6):592-607. PubMed ID: 21105952
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.
    Lambert JC; Berr C; Pasquier F; Delacourte A; Frigard B; Cottel D; Pérez-Tur J; Mouroux V; Mohr M; Cécyre D; Galasko D; Lendon C; Poirier J; Hardy J; Mann D; Amouyel P; Chartier-Harlin MC
    Hum Mol Genet; 1998 Sep; 7(9):1511-6. PubMed ID: 9700208
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia.
    Bartzokis G; Lu PH; Geschwind DH; Tingus K; Huang D; Mendez MF; Edwards N; Mintz J
    Biol Psychiatry; 2007 Dec; 62(12):1380-7. PubMed ID: 17659264
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma apolipoproteins and physical and cognitive health in very old individuals.
    Muenchhoff J; Song F; Poljak A; Crawford JD; Mather KA; Kochan NA; Yang Z; Trollor JN; Reppermund S; Maston K; Theobald A; Kirchner-Adelhardt S; Kwok JB; Richmond RL; McEvoy M; Attia J; Schofield PW; Brodaty H; Sachdev PS
    Neurobiol Aging; 2017 Jul; 55():49-60. PubMed ID: 28419892
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A role for apoE in regulating the levels of alpha-1-antichymotrypsin in the aging mouse brain and in Alzheimer's disease.
    Licastro F; Campbell IL; Kincaid C; Veinbergs I; Van Uden E; Rockenstein E; Mallory M; Gilbert JR; Masliah E
    Am J Pathol; 1999 Sep; 155(3):869-75. PubMed ID: 10487844
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polymorphism of apolipoprotein E influences levels of serum apolipoproteins E and B in the human neonate.
    Steinmetz A; Thiemann E; Czekelius P; Kaffarnik H
    Eur J Clin Invest; 1989 Aug; 19(4):390-4. PubMed ID: 2506056
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.
    Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N
    Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Apolipoprotein E polymorphism and Alzheimer's disease.
    Poirier J; Davignon J; Bouthillier D; Kogan S; Bertrand P; Gauthier S
    Lancet; 1993 Sep; 342(8873):697-9. PubMed ID: 8103819
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Apolipoprotein E polymorphism in Southern Iran: E4 allele in the lowest reported amounts.
    Bazrgar M; Karimi M; Fathzadeh M; Senemar S; Peiravian F; Shojaee A; Saadat M
    Mol Biol Rep; 2008 Dec; 35(4):495-9. PubMed ID: 17594534
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.
    Arendt T; Schindler C; Brückner MK; Eschrich K; Bigl V; Zedlick D; Marcova L
    J Neurosci; 1997 Jan; 17(2):516-29. PubMed ID: 8987775
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease.
    Roks G; Cruts M; Bullido MJ; Backhovens H; Artiga MJ; Hofman A; Valdivieso F; Van Broeckhoven C; Van Duijn CM
    Neurosci Lett; 1998 Dec; 258(2):65-8. PubMed ID: 9875528
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins.
    Sun Y; Wu S; Bu G; Onifade MK; Patel SN; LaDu MJ; Fagan AM; Holtzman DM
    J Neurosci; 1998 May; 18(9):3261-72. PubMed ID: 9547235
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.
    Town T; Paris D; Fallin D; Duara R; Barker W; Gold M; Crawford F; Mullan M
    Neurosci Lett; 1998 Aug; 252(2):95-8. PubMed ID: 9756330
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ApoE-dependent plasticity in Alzheimer's disease.
    Teter B
    J Mol Neurosci; 2004; 23(3):167-79. PubMed ID: 15181245
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The APOE Gene is Differentially Methylated in Alzheimer's Disease.
    Foraker J; Millard SP; Leong L; Thomson Z; Chen S; Keene CD; Bekris LM; Yu CE
    J Alzheimers Dis; 2015; 48(3):745-55. PubMed ID: 26402071
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Schizophrenia and apolipoprotein E gene polymorphism in Serbian population.
    Kecmanović M; Dobricić V; Dimitrijević R; Keckarević D; Savić-Pavićević D; Keckarević-Marković M; Ivkovic M; Romac S
    Int J Neurosci; 2010 Jul; 120(7):502-6. PubMed ID: 20583903
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Editorial comment--not all hypertensive subjects have similar risks for white matter lesions: influence of genetic factors.
    Leys D; Pasquier F
    Stroke; 2004 May; 35(5):1061-2. PubMed ID: 15073393
    [No Abstract]   [Full Text] [Related]  

  • 80. ApoE polymorphism in Polish patients with Alzheimer's disease.
    Lalowski MM; Czyzewski K; Pfeffer A; Barcikowska M; Kwieciński H
    Acta Neurobiol Exp (Wars); 1998; 58(1):65-8. PubMed ID: 9583189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.